BioSpace News Archive

Business

Oxford BioTherapeutics Licenses Nerviano Medical Sciences (NervianoMS)’ Drug-Linker Technology To Develop Novel Antibody Drug Conjugates

April 4, 2016
·
4 min read
Drug Development

AbbVie Receives CHMP Positive Opinion For HUMIRA (adalimumab) For The Treatment Of Pediatric Patients, From Six Years Of Age, With Moderately To Severely Active Crohn’s Disease

April 4, 2016
·
8 min read
Business

BioLife Solutions, Inc. Names Cord Blood Industry Veteran Karen Foster Vice President Of Operations

April 4, 2016
·
4 min read
Drug Development

Intec Pharma Ltd. Enrolls First Patient In Pivotal Phase III Clinical Trial Of AP-CDLD For Advanced Parkinson’s Disease Patients

April 4, 2016
·
6 min read
Drug Development

Biomarker Analyses Of Neuraltus Pharmaceuticals, Inc.’ NP001 Phase 2 Data Demonstrate Potential For Treating ALS Patients With Systemic Inflammation

April 4, 2016
·
5 min read
Drug Development

Citius Pharma Completes Acquisition Of Leonard-Meron Biosciences

April 4, 2016
·
6 min read
Drug Development

Neuraltus Pharmaceuticals, Inc. Announces Plans For Second Phase 2 Study Of NP001 In ALS Using Biomarker For Enriched Patient Selection

April 4, 2016
·
3 min read
Business

Innophos Holdings, Inc. Appoints Han Kieftenbeld As Chief Financial Officer

April 4, 2016
·
4 min read
Policy

ConforMIS Withdraws Application as the FDA Raises Questions on iTotal Hip

April 4, 2016
·
1 min read
FDA

Bracco Diagnostics Grabs First Approval by the FDA for Contrast Enhanced Ultrasonography of the Liver for LUMASON

April 4, 2016
·
7 min read